Penn Medicine

Mailed opioid disposal kits led to 60 percent of patients who had leftover opioid pain pills properly disposing of them after surgeries, according to a new study by researchers at the Perelman School of Medicine at the University of…

Historically, there has been racial inequity when it comes to primary care appointments, which are vital for managing and preventing chronic disease. But as COVID-19 struck the United States in 2020 and telemedicine availability rose…

A six-year study of nearly 100,000 women in Botswana has provided new evidence that relatively inexpensive daily diet supplementation of iron, folic acid and vitamin supplementation in pregnancy can reduce complications at birth.…

The Penn Urban Health Lab, along with 13 community and faith-based organizations, will launch Deeply Rooted, a community-driven program to promote health equity and environmental justice in Black and brown neighborhoods in West and…

To reveal how the immune system may drive health and disease in pregnant people and better understand how to best leverage vaccines to ensure maternal and fetal protection from infectious disease, a team of researchers has been awarded a…

The first bladder cancer drug targeting a cancer-driving gene mutation has been used relatively little despite its clear efficacy in a clinical trial, suggests a study from researchers at the Perelman School of Medicine at the University…

Researchers at the Abramson Cancer Center at the University of Pennsylvania have found a way to identify lung cancer at the cellular level in real time during a biopsy, offering promise in the ability to detect the disease earlier and…

Penn Medicine and Children’s Hospital of Philadelphia (CHOP), who together pioneered the research and development of the world’s first personalized cellular therapy for cancer — also known as CAR T cell therapy — have announced plans with…

For first-year Perelman School of Medicine (PSOM) student Bryson Houston, the Penn Access Summer Scholars (PASS) Program helped solidify his passion for medicine and grow a supportive network. Through PASS, in 2019 and 2020 the Morehouse…

The U.S. Food and Drug Administration (FDA) has expanded its approval for a personalized cellular therapy developed at the University of Pennsylvania’s Abramson Cancer Center, this time for the treatment of adults with relapsed or…